Literature DB >> 10323242

Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.

S S Li1, H M Tseng, T P Yang, C H Liu, S J Teng, H W Huang, L M Chen, H W Kao, J H Chen, J N Tseng, A Chen, M F Hou, T J Huang, H T Chang, K T Mok, J H Tsai.   

Abstract

A total of 18 families with multiple cases of breast cancer were identified from southern Taiwan, and 5 of these families were found to carry cancer-associated germline mutations in the BRCA1 and BRCA2 genes. One novel cryptic splicing mutation of the BRCA1 gene, found in two unrelated families, was shown to be a deletion of 10 bp near the branch site in intron 7. This mutation causes an insertion of 59 nucleotides derived from intron 7 and results in a frameshift, leading to premature translational termination of BRCA1 mRNA in exon 8. Deletions of 2670delC, 3073delT and 6696-7delTC in the BRCA2 gene were found in three other breast cancer families. All three deletions are predicted to generate frameshifts and to result in the premature termination of BRCA2 protein translation. Several genetic polymorphisms in both BRCA1 and BRCA2 genes were also detected in this investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323242     DOI: 10.1007/s004390050936

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

Review 1.  Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.

Authors:  Ava Kwong; Vivian Y Shin; John C W Ho; Eunyoung Kang; Seigo Nakamura; Soo-Hwang Teo; Ann S G Lee; Jen-Hwei Sng; Ophira M Ginsburg; Allison W Kurian; Jeffrey N Weitzel; Man-Ting Siu; Fian B F Law; Tsun-Leung Chan; Steven A Narod; James M Ford; Edmond S K Ma; Sung-Won Kim
Journal:  J Med Genet       Date:  2015-07-17       Impact factor: 6.318

2.  Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.

Authors:  Ava Kwong; L P Wong; H N Wong; F B F Law; E K O Ng; Y H Tang; W K Chan; D T K Suen; C Choi; L S Ho; K H Kwan; M Poon; T T Wong; K Chan; S W W Chan; M W L Ying; W C Chan; E S K Ma; J M Ford; D W West
Journal:  Hugo J       Date:  2010-04-10

3.  Biased exon/intron distribution of cryptic and de novo 3' splice sites.

Authors:  Jana Královicová; Mikkel B Christensen; Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2005-09-01       Impact factor: 16.971

4.  Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Authors:  Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2006-09-08       Impact factor: 16.971

5.  The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.

Authors:  S Sivagnanasundaram; I Islam; I Talbot; F Drummond; J R Walters; Y H Edwards
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

6.  Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.

Authors:  Xiaochen Yang; Jiong Wu; Jingsong Lu; Guangyu Liu; Genhong Di; Canming Chen; Yifeng Hou; Menghong Sun; Wentao Yang; Xiaojing Xu; Ying Zhao; Xin Hu; Daqiang Li; Zhigang Cao; Xiaoyan Zhou; Xiaoyan Huang; Zhebin Liu; Huan Chen; Yanzi Gu; Yayun Chi; Xia Yan; Qixia Han; Zhenzhou Shen; Zhimin Shao; Zhen Hu
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

7.  Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

Authors:  Guo-Yan Liu; Wei Zhang
Journal:  Chin J Cancer       Date:  2011-12-16

8.  Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China.

Authors:  Jianghua Ou; Tao Wu; Rolf Sijmons; Duo Ni; Wenting Xu; Halmurat Upur
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

Review 9.  Hereditary breast cancer in the Han Chinese population.

Authors:  Wenming Cao; Xiaojia Wang; Ji-Cheng Li
Journal:  J Epidemiol       Date:  2013-01-12       Impact factor: 3.211

10.  Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.

Authors:  Nicholas C Hsu; Ya-Fang Huang; Kazunari K Yokoyama; Pei-Yi Chu; Fang-Ming Chen; Ming-Feng Hou
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.